Haleon (NYSE:HLN) Stock Rating Reaffirmed by Argus

Haleon (NYSE:HLN)‘s stock had its “buy” rating reissued by investment analysts at Argus in a note issued to investors on Tuesday, March 26th, Benzinga reports.

Haleon Stock Performance

NYSE HLN traded down $0.08 during trading hours on Tuesday, reaching $8.26. The stock had a trading volume of 6,131,609 shares, compared to its average volume of 5,569,931. Haleon has a 52-week low of $7.70 and a 52-week high of $9.05. The stock has a fifty day moving average of $8.32 and a 200 day moving average of $8.29. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.73 and a current ratio of 1.04. The stock has a market cap of $38.14 billion, a P/E ratio of 29.79, a price-to-earnings-growth ratio of 2.22 and a beta of 0.29.

Institutional Trading of Haleon

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Washington Trust Advisors Inc. grew its position in Haleon by 353.3% during the third quarter. Washington Trust Advisors Inc. now owns 2,960 shares of the company’s stock valued at $25,000 after buying an additional 2,307 shares during the period. Farther Finance Advisors LLC raised its stake in shares of Haleon by 79.3% during the 2nd quarter. Farther Finance Advisors LLC now owns 2,986 shares of the company’s stock worth $25,000 after buying an additional 1,321 shares during the period. CoreFirst Bank & Trust purchased a new position in shares of Haleon during the 4th quarter valued at approximately $26,000. Barclays PLC increased its holdings in Haleon by 56.4% in the 2nd quarter. Barclays PLC now owns 3,317 shares of the company’s stock worth $28,000 after acquiring an additional 1,196 shares in the last quarter. Finally, Resurgent Financial Advisors LLC acquired a new position in Haleon during the fourth quarter worth $29,000. 6.67% of the stock is owned by institutional investors and hedge funds.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.